Description |
apolipoprotein H |
lipoprotein(a) |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Abdominal aortic aneurysm ( 32981348)
- Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis) ( 32678081)
- Aortic valve stenosis ( 29511194)
- Aortic-valve calcification ( 23388002)
- Apolipoprotein A1 levels ( 32203549 33730874)
- Apolipoprotein B levels ( 32203549)
- Blood protein levels ( 28240269)
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Body shape index ( 34021172)
- C-reactive protein levels ( 33339817)
- Calcific aortic valve stenosis ( 32141789)
- Cholesterol, total ( 24097068 28270201 25961943 20686565)
- Coronary artery disease ( 32469254 29212778 24262325 30104761 26343387 28714974 33020668)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- Coronary artery disease in diabetes ( 30003307)
- Coronary artery disease or ischemic stroke ( 24262325)
- Coronary artery disease or large artery stroke ( 24262325)
- Coronary heart disease ( 19198611 21378990)
- End stage renal disease x APOL1 genotype interaction ( 29885931)
- HDL cholesterol ( 25961943 20686565)
- HDL cholesterol levels ( 32203549)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Heart failure ( 31919418)
- High density lipoprotein cholesterol levels ( 33339817)
- Hip circumference adjusted for BMI ( 34021172)
- Ischemic stroke (large artery atherosclerosis) ( 29531354)
- LDL cholesterol ( 24097068 30275531 25961943 20686565)
- LDL cholesterol levels ( 32203549)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Lipid or lipoprotein levels ( 23696881)
- Lipoprotein (a) levels ( 26377243 30108283 33115273 28512139)
- Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention) ( 31186284)
- Lipoprotein (a) levels in response to niacin in statin-treated individuals ( 30371334)
- Lipoprotein phospholipase A2 activity in cardiovascular disease ( 28753643)
- Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms ( 28512139)
- Lipoprotein-associated phospholipase A2 activity change in response to statin therapy ( 23118302)
- Low density lipoprotein cholesterol levels ( 32154731 33339817)
- Low density lipoprotein cholesterol levels (on statin treatment) ( 31969989)
- Lp (a) levels ( 21900290 19124843)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (antithrombotic agents) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Medication use (salicylic acid and derivatives) ( 31015401)
- Medication use (vasodilators used in cardiac diseases) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolite levels (lipoprotein measures) ( 27005778)
- Minimum ankle–brachial index ( 31285632)
- Monocyte early outgrowth colony forming units ( 21493818)
- Myocardial infarction ( 33532862 26343387)
- Parental lifespan ( 30642433 29030599)
- Parental longevity (both parents in top 10%) ( 29227965)
- Parental longevity (combined parental age at death) ( 29227965)
- Parental longevity (combined parental attained age, Martingale residuals) ( 29227965)
- Parental longevity (father's age at death) ( 31484785 29227965)
- Parental longevity (father's attained age) ( 29227965)
- Parental longevity (mother's age at death or mother's attained age) ( 31484785)
- Parental longevity (mother's age at death) ( 29227965)
- Parental longevity (mother's attained age) ( 29227965)
- Peripheral artery disease ( 31285632)
- Plasma plasminogen levels ( 25208887)
- Plateletcrit ( 32888494)
- Protein quantitative trait loci ( 18464913)
- Response to statin therapy ( 22368281)
- Response to statins (LDL cholesterol change) ( 25350695 22331829 31969989)
- Response to statins (LDL cholesterol percent change) ( 31969989)
- Total cholesterol levels ( 28334899 33339817 30275531)
- Triglyceride levels ( 32203549 32154731)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 30275531 25961943)
- Urinary albumin excretion ( 32277301)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172)
|
Interacting Genes |
14 interacting genes:
AKT1
ANXA2
CDC42
CLEC4G
F10
F12
GEM
GRB2
LPA
LRP2
LRP8
OGT
PLG
RBBP6
|
9 interacting genes:
APOH
CANX
CELA1
ELANE
FBLN5
FGB
FN1
LRP2
MMP12
|
Entrez ID |
350 |
4018 |
HPRD ID |
00728 |
01063 |
Ensembl ID |
ENSG00000091583
|
ENSG00000198670
|
Uniprot IDs |
A0A384NKM6
P02749
|
|
PDB IDs |
1C1Z
1G4F
1G4G
1QUB
2KRI
3OP8
4JHS
6V06
6V08
6V09
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|